American Journal of Clinical Dermatology

Article	Citations
Cutaneous Manifestations of COVID-19: An Evidence-Based Review	109
The Skin Microbiome: A New Actor in Inflammatory Acne	108
Skin Microbiota and its Interplay with Wound Healing	92
Sunscreens and Photoaging: A Review of Current Literature	84
Rosacea: New Concepts in Classification and Treatment	78
Use of IL-23 Inhibitors for the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review	76
Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis	70
Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib and Abrocitinib	66
Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study	63
Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program	62
Psychosocial Effects of Vitiligo: A Systematic Literature Review	60
Effects of Diet on Acne and Its Response to Treatment	58
Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments	57
New and Emerging Targeted Therapies for Vascular Malformations	55
Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1)	54
Dermatitis Herpetiformis: An Update on Diagnosis and Management	53
Treatment Options and Goals for Patients with Generalized Pustular Psoriasis	52
Skin Microbiome and its Interplay with the Environment	52
Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review	52
Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic	51
Erythema Nodosum: A Practical Approach and Diagnostic Algorithm	50
Clinical Course and Characteristics of Generalized Pustular Psoriasis	49
Dermatological Toxicities of Bruton’s Tyrosine Kinase Inhibitors	47
Pathophysiology of Generalized Pustular Psoriasis	44
A Review of Noninvasive Techniques for Skin Cancer Detection in Dermatology	43

Ceramides in Skin Health and Disease: An Update	42
The Growing Problem of Antifungal Resistance in Onychomycosis and Other Superficial Mycoses	41
Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational Study	38
Granuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options	37
Skin Microbiome as Years Go By	35
New Practical Aspects of Sweet Syndrome	33
Pharmacokinetics of Ruxolitinib in Patients with Atopic Dermatitis Treated With Ruxolitinib Cream: Data from Phase II and III Studies	33
Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis	32
Deucravacitinib for the Treatment of Psoriatic Disease	32
Teledermatology During COVID-19: An Updated Review	32
Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma	31
Microbiota in Rosacea	30
New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review	30
Cutaneous Leishmaniasis: A 2022 Updated Narrative Review into Diagnosis and Management Developments	30
Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE)	29
Long-Term Outcomes in BRAF-Mutated Melanoma Treated with Combined Targeted Therapy or Immune Checkpoint Blockade: Are We Approaching a True Cure?	28
A Review Comparing International Guidelines for the Management of Bullous Pemphigoid, Pemphigoid Gestationis, Mucous Membrane Pemphigoid, and Epidermolysis Bullosa Acquisita	28
The Prevalence and Disease Characteristics of Generalized Pustular Psoriasis	28
Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials	28
Botulinum Toxin Type B for Hidradenitis Suppurativa: A Randomised, Double-Blind, Placebo-Controlled Pilot Study	27
Eosinophilic Dermatoses: Recognition and Management	27
Efficacy and Safety of SHR0302, a Highly Selective Janus Kinase 1 Inhibitor, in Patients with Moderate to Severe Atopic Dermatitis: A Phase II Randomized Clinical Trial	27
50 Years of Topical Retinoids for Acne: Evolution of Treatment	27
Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata	26
Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outco	26
Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review	25
Clinical Disease Measures in Generalized Pustular Psoriasis	25
Impact of Generalized Pustular Psoriasis from the Perspective of People Living with the Condition: Results of an Online Survey	24
The Importance of Incorporating Human Factors in the Design and Implementation of Artificial Intelligence for Skin Cancer Diagnosis in the Real World	24
Investigational Treatments for Epidermolysis Bullosa	24
An Update on the Role of Talimogene Laherparepvec (T-VEC) in the Treatment of Melanoma: Best Practices and Future Directions	24
The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma	24
JAK in the [Black] Box: A Dermatology Perspective on Systemic JAK Inhibitor Safety	23
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)	23
The Role of the Microbiome and Microbiome-Derived Metabolites in Atopic Dermatitis and Non-Histaminergic Itch	23
Lack of Evidence for an Increased Risk of Severe COVID-19 in Psoriasis Patients on Biologics: A Cohort Study from Northeast Italy	23
Effects of Topical Retinoids on Acne and Post-inflammatory Hyperpigmentation in Patients with Skin of Color: A Clinical Review and Implications for Practice	23
Maintenance of Response Through up to 4 Years of Continuous Guselkumab Treatment of Psoriasis in the VOYAGE 2 Phase 3 Study	23
Steroid Phobia: A Review of Prevalence, Risk Factors, and Interventions	21
Efficacy of Nonprescription Moisturizers for Atopic Dermatitis: An Updated Review of Clinical Evidence	20
Cigarette Smoking, Alcohol Consumption, and Risk of Alopecia Areata: A Population-Based Cohort Study in Taiwan	20
New Topical Therapies for Psoriasis	19
The Pathogenesis and Management of Acne-Induced Post-inflammatory Hyperpigmentation	19
Emerging Therapeutic Options for Chronic Pruritus	19
What’s New in Topicals for Atopic Dermatitis?	19
Behçet Disease: An Update for Dermatologists	18
Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study	18
HLA-Cw1 and Psoriasis	18
Fabric Selection in Atopic Dermatitis: An Evidence-Based Review	18
Diagnosis of Generalized Pustular Psoriasis	18

Time to Relapse After Discontinuing Systemic Treatment for Psoriasis: A Systematic Review	17
Dermatologic Laser Side Effects and Complications: Prevention and Management	17
Vitiligo and Melanoma-Associated Vitiligo: Understanding Their Similarities and Differences	17
Impact of Facial Atrophic Acne Scars on Quality of Life: A Multi-country Population-Based Survey	17
A Maximum-Use Trial of Ruxolitinib Cream in Adolescents and Adults with Atopic Dermatitis	17
Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System	16
Long-Term Outcomes of Immune Checkpoint Inhibition in Metastatic Melanoma	16
Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics	16
Treatment Goals in Psoriasis: Which Outcomes Matter Most?	16
DPP-4 Inhibitors and Increased Reporting Odds of Bullous Pemphigoid: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS) from 2006 to 2020	16
Granulomatous Cutaneous Drug Eruptions: A Systematic Review	16
Effect of Dupilumab on Laboratory Parameters in Adolescents with Atopic Dermatitis: Results from a Randomized, Placebo-Controlled, Phase 3 Clinical Trial	15
Combining BRAF/MEK Inhibitors with Immunotherapy in the Treatment of Metastatic Melanoma	15
Vulvar Melanoma: Molecular Characteristics, Diagnosis, Surgical Management, and Medical Treatment	15
Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis	15
A Review of Existing Therapies for Actinic Keratosis: Current Status and Future Directions	15
Pruritus in Pregnancy	15
New and Emerging Biologics for Atopic Dermatitis	14
Pediatric Mastocytosis: Recognition and Management	14
Hormonal Contraceptives and Dermatology	14
Tralokinumab for the Treatment of Atopic Dermatitis	14
Expert Perspectives on Key Parameters that Impact Interpretation of Randomized Clinical Trials in Moderate-to-Severe Atopic Dermatitis	14
Cutaneous Manifestations of SARS-CoV-2 Infection	14
Dermatologic Sequelae Associated with Radiation Therapy	13
Identifying the Impacts of Acne and the Use of Questionnaires to Detect These Impacts: A Systematic Literature Review	13
Culprit Medications and Risk Factors Associated with Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Population-Based Nested Case–Control Study	13
Malignancy Rates in Brodalumab Clinical Studies for Psoriasis	13
Hypertrophic Scars and Keloids: Advances in Treatment and Review of Established Therapies	12
Baricitinib: A Review in Moderate to Severe Atopic Dermatitis	12
The Role of Diet Modification in Atopic Dermatitis: Navigating the Complexity	12
Laser Treatment for Non-Melanoma Skin Cancer: A Systematic Review and Meta-Analysis	12
Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization and Mortality in Patients with Psoriasis: A Population-Based Study	12
Mechanisms of Resistance to BRAF-Targeted Melanoma Therapies	12
Oral Antibiotics for Acne	12
Photoprotection for Skin of Color	12
Antibiotic Resistance in Acne: Mechanisms, Complications and Management	11
Cellulitis: A Review of Current Practice Guidelines and Differentiation from Pseudocellulitis	11
Economic Burden of Chronic Hand Eczema: A Review	11
Update in Diagnosis and Management of Primary Cutaneous B-Cell Lymphomas	11
Cardiovascular Safety of Biologics Targeting Interleukin (IL)-12 and/or IL-23: What Does the Evidence Say?	11
Skin Cancer in People of Color: A Systematic Review	11
Cholestatic Itch: Our Current Understanding of Pathophysiology and Treatments	11
More Severe Erosive Phenotype Despite Lower Circulating Autoantibody Levels in Dipeptidyl Peptidase-4 Inhibitor (DPP4i)-Associated Bullous Pemphigoid: A Retrospective Cohort Study	10
Recommendations for Vaccination in Children with Atopic Dermatitis Treated with Dupilumab: A Consensus Meeting, 2020	10
Advances in Topical Treatments of Cutaneous Malignancies	10
Leukonychia: What Can White Nails Tell Us?	10
Effect of Vitamin D Serum Levels and Supplementation on Atopic Dermatitis: A Systematic Review and Meta-analysis	10
Stasis Dermatitis: An Overview of Its Clinical Presentation, Pathogenesis, and Management	10
A Practical Approach to the Diagnosis and Management of Classic Lichen Planopilaris	10
Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination	10
Primary Localized Cutaneous Amyloidosis of Keratinocyte Origin: An Update with Emphasis on Atypical Clinical Variants	9
Progress to Date in Advancing Stratified Medicine in Psoriasis	9
Alternative Clinical Indications of Botulinum Toxin	9
Surgical Site Infection After Dermatologic Procedures: Critical Reassessment of Risk Factors and Reappraisal of Rates and Causes	9
The Use of Lasers and Light Devices in Acne Management: An Update	9
The Botfly, A Tropical Menace: A Distinctive Myiasis Caused by Dermatobia hominis	9
Acne Keloidalis Nuchae and the Metabolic Syndrome: A Population-Based Study	9
Psoriasis in Patients with Metabolic Syndrome or Type 2 Diabetes Mellitus: Treatment Challenges	9
Eczematous Drug Eruptions	9
Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview	8
The Skin and Gut Microbiome in Hidradenitis Suppurativa: Current Understanding and Future Considerations for Research and Treatment	8
Evaluating the Longitudinal Course of Atopic Dermatitis: Implications for Clinical Practice	8
Dupilumab Facial Redness/Dupilumab Facial Dermatitis: A Guide for Clinicians	8
Therapeutic Drug Monitoring in Patients with Suboptimal Response to Adalimumab for Hidradenitis Suppurativa: A Retrospective Case Series	8
Generalized Pustular Psoriasis in Pregnancy: Current and Future Treatments	8
Management of Difficult-to-Treat Warts: Traditional and New Approaches	8
Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions	8
Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials	8
Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial	8
Treating Acne in Transgender Persons Receiving Testosterone: A Practical Guide	8
The Impact of Hyperhidrosis on Quality of Life: A Review of the Literature	8
Metformin Therapy for Acne in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis	8
Novel Therapies for Pemphigus Vulgaris	8
Appraisal of Proactive Topical Therapy in Atopic Dermatitis: Pros and Cons	7
Comparison of the Efficacy and Safety of Apremilast and Methotrexate in Patients with Palmoplantar Psoriasis: A Randomized Controlled Trial	7
Combination Therapy with Apremilast and Biologics for Psoriasis: A Systematic Review	7
Management of Coexisting Bullous Pemphigoid and Psoriasis: A Review	7
Review of Perineural Invasion in Keratinocyte Carcinomas	7
New Developments in Topical Acne Therapy	7
Vitiligo Treatments: Review of Current Therapeutic Modalities and JAK Inhibitors	7

Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?	6
Methotrexate Cutaneous Ulceration: A Systematic Review of Cases	6
Early Itch Response with Abrocitinib Is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE COMPARE Trial	6
Medical Management of Hidradenitis Suppurativa with Non-Biologic Therapy: What’s New?	6
Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials	6
Treatment of Hyperhidrosis: An Update	6
Efficacy and Safety of Sonic Hedgehog Inhibitors in Basal Cell Carcinomas: An Updated Systematic Review and Meta-analysis (2009–2022)	6
What’s New in Therapy for Male Androgenetic Alopecia?	6
Impact of Circulating and Tissue Biomarkers in Adjuvant and Neoadjuvant Therapy for High-Risk Melanoma: Ready for Prime Time?	6
Syphilis in Dermatology: Recognition and Management	6
Repurposing Ophthalmologic Timolol for Dermatologic Use: Caveats and Historical Review of Adverse Events	6
Curbing COVID-19 Vaccine Hesitancy from a Dermatological Standpoint: Analysis of Cutaneous Reactions in the Vaccine Adverse Event Reporting System (VAERS) Database	6
Therapeutic Strategies for Untreated Capillary Malformations of the Head and Neck Region: A Systematic Review and Meta-Analyses	6
Differential Diagnosis, Prevention, and Treatment of mpox (Monkeypox): A Review for Dermatologists	6